These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

225 related articles for article (PubMed ID: 9201177)

  • 41. Surgical management of incompletely excised basal cell carcinomas of the head and neck.
    Wilson AW; Howsam G; Santhanam V; Macpherson D; Grant J; Pratt CA; Townend JV
    Br J Oral Maxillofac Surg; 2004 Aug; 42(4):311-4. PubMed ID: 15225948
    [TBL] [Abstract][Full Text] [Related]  

  • 42. How Wide Should the Excision Margins for Facial Small Aggressive Basal Cell Carcinoma Be? Experience With 306 Cases.
    Ariza SA; Calderón DC; Aristizábal JC; Parra-Medina R
    Dermatol Surg; 2020 Jun; 46(6):753-756. PubMed ID: 31567587
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Do basal cell carcinomas recur after complete conventional surgical excision?
    Griffiths RW; Suvarna SK; Stone J
    Br J Plast Surg; 2005 Sep; 58(6):795-805. PubMed ID: 16086990
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Recurrent basal cell carcinoma: a clinicopathological study and evaluation of histomorphological findings in primary and recurrent lesions.
    Bartoš V; Pokorný D; Zacharová O; Haluska P; Doboszová J; Kullová M; Adamicová K; Péč M; Péč J
    Acta Dermatovenerol Alp Pannonica Adriat; 2011 Jun; 20(2):67-75. PubMed ID: 21993704
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Increased Marginal Stiffness Differentiates Infiltrative From Noninfiltrative Cutaneous Basal Cell Carcinomas in the Facial Area: A Prospective Study.
    Alfageme F; Salgüero I; Nájera L; Suarez ML; Roustan G
    J Ultrasound Med; 2019 Jul; 38(7):1841-1845. PubMed ID: 30467885
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Margin-Controlled, Staged Surgical Excision in the Treatment of High-Risk Basal Cell Carcinomas of the Head and Neck Region.
    Durmus Ucar AN; Durmus Kocaaslan FN; Salman A; Demirkesen C; Erdem Bayram F; Bayramicli M
    J Cutan Med Surg; 2019; 23(3):258-264. PubMed ID: 30556424
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Surgical treatment of basal cell carcinoma: a case series on factors influencing the risk of an incomplete primary excision.
    Kappelin J; Nielsen K; Nilsson F; Bjellerup M; Ahnlide I
    J Eur Acad Dermatol Venereol; 2020 Nov; 34(11):2518-2525. PubMed ID: 32124503
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Head and neck basal cell carcinoma: treatment using a 2-mm clinical excision margin.
    Lalloo MT; Sood S
    Clin Otolaryngol Allied Sci; 2000 Oct; 25(5):370-3. PubMed ID: 11012649
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Surgical margin marking for high-risk basal cell carcinomas of the cephalic region: a single-centre experience.
    Cecchi R; Bartoli L; Brunetti L; Pavesi M; Rapicano V
    G Ital Dermatol Venereol; 2011 Apr; 146(2):79-84. PubMed ID: 21505392
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Using frozen section margin control technique to manage non-melanomatous skin lesions in high-risk sites.
    Nizamoglu M; Douglas H; McArdle C; Mathew B; Vize C; Matteucci P
    J Plast Reconstr Aesthet Surg; 2016 May; 69(5):657-62. PubMed ID: 26850755
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Basal Cell Carcinoma in the Southern Health Area of Tenerife. Key Clinical and Pathological Factors and Margin Status After Excision.
    Loizate Sarrionandia I; de-la-Rosa Fernández E; González Rodríguez J; Hernández Hernández MN; Pelegrina ME; Castro Tarruella MV; Suárez Hernández J; Fernández-de-Misa Cabrera R
    Actas Dermosifiliogr; 2023 Sep; 114(8):674-679. PubMed ID: 37100344
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Small margin (up to 2 mm) excision of periocular basal cell carcinomas in the setting of a one-stop clinic - long-term outcomes at a minimum of 11 years' follow-up.
    Peden R; Radwan M; Wright M
    Eye (Lond); 2020 Nov; 34(11):2036-2040. PubMed ID: 31965082
    [TBL] [Abstract][Full Text] [Related]  

  • 53. bcl-2 protein expression in aggressive and non-aggressive basal cell carcinomas.
    Ramdial PK; Madaree A; Reddy R; Chetty R
    J Cutan Pathol; 2000 Jul; 27(6):283-91. PubMed ID: 10885404
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Additional review of Mohs slides to optimize Mohs micrographic surgery.
    van Lee CB; Graafland B; Koljenović S; Neumann HA; Nasserinejad K; Nijsten TE; van den Bos RR; Munte K
    Br J Dermatol; 2015 Jul; 173(1):123-7. PubMed ID: 25708878
    [TBL] [Abstract][Full Text] [Related]  

  • 55. [The margin of safety and depth of excision in surgical treatment of basalioma. Use of 3-dimensional histologic study of 2,016 tumors].
    Breuninger H; Schippert W; Black B; Rassner G
    Hautarzt; 1989 Nov; 40(11):693-700. PubMed ID: 2606668
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Infiltrative basal cell carcinoma occurring in sites of biopsy-proven nodular basal cell carcinoma.
    Swetter SM; Yaghmai D; Egbert BM
    J Cutan Pathol; 1998 Sep; 25(8):420-5. PubMed ID: 9826167
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Attributes and risk factors of positive margins on 864 excisions of basal cell carcinomas: a single-center retrospective study.
    Filho RB; de Carvalho Fantini B; Dos Santos CA; Melo RVG; Rosan I; Chahud F; da Silva Souza C
    J Dermatolog Treat; 2020 Sep; 31(6):589-596. PubMed ID: 31751157
    [No Abstract]   [Full Text] [Related]  

  • 58. Management of Incompletely Excised Skin Tumors: Our Experience.
    Robertson BF; Wokes JET; Siddiqui H
    Dermatol Surg; 2018 Mar; 44(3):365-369. PubMed ID: 29053539
    [TBL] [Abstract][Full Text] [Related]  

  • 59. [Low 5-year recurrence rate after surgical excision of 126 basal cell carcinomas with frozen section analysis upon indication].
    van der Meer GT; Willemse F; Marck KW
    Ned Tijdschr Geneeskd; 2001 Jul; 145(29):1409-13. PubMed ID: 11494691
    [TBL] [Abstract][Full Text] [Related]  

  • 60. The management of locally advanced head and neck squamous and basal cell carcinomas.
    Diamantopoulos P; Deskoulidi P; Dalianoudis I; Farazi Chongouki C; Maltzaris N; Agorogiannis D; Filippou D; Kotrotsiou M; Skandalakis P; Stavrianos S
    J BUON; 2018; 23(4):1118-1124. PubMed ID: 30358220
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.